WO2018145622A1 - Method for preparing salvianolic acid a salt - Google Patents

Method for preparing salvianolic acid a salt Download PDF

Info

Publication number
WO2018145622A1
WO2018145622A1 PCT/CN2018/075398 CN2018075398W WO2018145622A1 WO 2018145622 A1 WO2018145622 A1 WO 2018145622A1 CN 2018075398 W CN2018075398 W CN 2018075398W WO 2018145622 A1 WO2018145622 A1 WO 2018145622A1
Authority
WO
WIPO (PCT)
Prior art keywords
salvianolic acid
salt
water
aqueous solution
acid
Prior art date
Application number
PCT/CN2018/075398
Other languages
French (fr)
Chinese (zh)
Inventor
潘迎锋
凌益平
刘雳
付玲珠
朱晨
张丽
张平
刘晓云
应旭辉
史立人
Original Assignee
正大青春宝药业有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 正大青春宝药业有限公司 filed Critical 正大青春宝药业有限公司
Publication of WO2018145622A1 publication Critical patent/WO2018145622A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Definitions

  • the invention relates to a preparation method of salvianolic acid A salt.
  • Salvianic acid A is a water-soluble phenolic acid compound contained in Salvia miltiorrhiza. It was first isolated from Salvia miltiorrhiza in 1984 by Professor Li Lian Niang (LiLian-Niang, et al. Planta Medica. 1984, 50: 227). Salvianolic acid A has strong pharmacological activities such as myocardial ischemia protection, antithrombotic, anti-fibrosis and anti-oxidation, and has potential therapeutic value for cardiovascular and cerebrovascular diseases.
  • salvianolic acid A The presence of salvianolic acid A is easily oxidized and has poor stability, and it is difficult to ensure long-term stability in various dosage forms.
  • CN105523926 A discloses a method for extracting and separating and purifying salvianolic acid A and a method for preparing salvianolic acid A salt, wherein a magnesium salt of salvianolic acid A is used, but the obtained method comprises sodium chloride or potassium chloride.
  • Magnesium salt complex discloses a preparation method of salvianolic acid A magnesium salt, which has the advantages of complicated process flow, high production cost, and is not suitable for industrial production or preparation.
  • the object of the present invention is to provide a preparation method of salvianolic acid A salt which has high stability, is not easily oxidized, and has high purity.
  • the preparation method has the advantages of good processability, simple operation, low production cost, and is suitable for industrial production or preparation. specialty.
  • a method for preparing salvianolic acid A salt wherein the preparation method is:
  • the salvianolic acid A is dissolved in water, and the pH is adjusted to a pH of 1.2 to 5.5 (preferably 3.2 to 4.2) with an aqueous solution of an alkaline substance, and the precipitate is collected to be the salvianolic acid A salt.
  • the mass ratio of the salicylic acid A to water is 1:0.25 to 4, preferably 1:0.67 to 1.5.
  • the concentration of the aqueous solution of the alkaline substance is 1% to 15%, preferably 4% to 11%; the alkaline substance includes a strong base, a weak acid strong base salt, specifically, for example, sodium hydroxide, sodium hydrogencarbonate, carbonic acid Sodium, potassium hydroxide, potassium hydrogencarbonate, potassium carbonate, magnesium hydroxide, magnesium hydrogencarbonate, magnesium carbonate, calcium hydroxide, calcium hydrogencarbonate, calcium carbonate, sodium citrate, sodium tartrate, potassium citrate, potassium tartrate, lemon Magnesium or magnesium tartrate.
  • a strong base specifically, for example, sodium hydroxide, sodium hydrogencarbonate, carbonic acid Sodium, potassium hydroxide, potassium hydrogencarbonate, potassium carbonate, magnesium hydroxide, magnesium hydrogencarbonate, magnesium carbonate, calcium hydroxide, calcium hydrogencarbonate, calcium carbonate, sodium citrate, sodium tartrate, potassium citrate, potassium tartrate, lemon Magnesium or magnesium tartrate.
  • the salvianolic acid A salt obtained by the present invention is a sodium salt, a potassium salt, a magnesium salt or a calcium salt of salvianolic acid A.
  • the collected precipitates are washed with water and dried, and then directly used in the preparation or used together with a human acceptable pharmaceutical excipient for the preparation.
  • the salvianolic acid A of the invention is obtained by extracting raw material Danshen by water or ethanol aqueous solution, separating by macroporous resin column chromatography and separating by polyamide chromatography column.
  • the preparation method for example, the method disclosed in Chinese Patent No. CN101361728 B can be referred to.
  • the preparation method of the salvianolic acid A is generally:
  • the raw material Salvia miltiorrhiza is the dried root and rhizome of Salvia miltiorrhiza Bge., which is commercially available on the market;
  • the macroporous resin is HPD-100, HPD-100A, HPD-300, HPD-400, HPD-400A, HPD-450, D101, 1300-I, 1400 or AB-8;
  • the organic solvent used for the extraction is ethyl acetate, propyl acetate, butyl acetate, n-butanol or isopropanol;
  • the obtained salvianolic acid A has a purity of 50% to 100%, and can be directly used for the preparation of the subsequent salvianolic acid A salt.
  • the invention has the beneficial effects that the invention adopts a method for increasing the pH and extracting the salvianolic acid A salt by adding an alkali solution in the aqueous solution of salvianolic acid A, and preparing a method which has strong stability, is not easily oxidized, has high purity, and has reduced impurities. Phenolic acid A salt product.
  • the preparation method is simple and more suitable for industrial large production. Therefore, the present invention provides an efficient and simple method for the preparation of salvianolic acid A salt, which is beneficial to the development and application of salvianolic acid A salt.
  • Figure 1 High resolution mass spectrum of salvianolic acid A sodium salt
  • Figure 2 1 H NMR spectrum of salvianolic acid A sodium salt
  • Examples 1 to 9 are preparation examples of salvianolic acid A, and refer to the method disclosed in CN 101361728 B.
  • Raw material danshen was purchased from Shanghai Huayu Pharmaceutical Co., Ltd.
  • the raw material Danshen 200kg and the volume fraction 50% ethanol aqueous solution 2000L were mixed, extracted at 82 ° C for 2h, the filtrate was collected by filtration, the filter residue was re-extracted 3 times, and the obtained filtrate was combined to obtain Salvia miltiorrhiza extract; the obtained Salvia miltiorrhiza extract was concentrated to 600L, adjust the pH to 4.5 with hydrochloric acid, heat to 120 ° C for 4h, then cool to room temperature, filter, filtrate for HPD-100 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution Then, elute with a 50% aqueous solution of ethanol, collect the eluate containing salvianolic acid A, concentrate to an alcohol-free taste, and continue to separate the polyamide column, first elute with water and a volume fraction of 35% ethanol solution.
  • the raw material Danshen 200kg and the volume fraction 50% ethanol aqueous solution 2000L were mixed, extracted at 82 ° C for 2h, the filtrate was collected by filtration, the filter residue was double-recovered twice, and the obtained filtrate was combined to obtain the Salvia miltiorrhiza extract; the obtained Salvia miltiorrhiza extract was concentrated to 400L, adjust the pH to 4.4 with hydrochloric acid solution, heat to 120 ° C for 2.5h, then cool to room temperature, filter, filtrate for HPD-300 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution Miscellaneous, and then eluted with a 50% aqueous solution of ethanol, collected eluate containing salvianolic acid A, concentrated to an alcohol-free taste, and then separated on a polyamide column, first eluted with water, a volume fraction of 35% ethanol After removing impurities, elute with a 75% aqueous solution of ethanol, collect the
  • the raw material Danshen 200kg and the volume fraction 50% ethanol aqueous solution 2000L were mixed, extracted at 82 ° C for 2h, the filtrate was collected by filtration, the filter residue was double-recovered twice, and the obtained filtrate was combined to obtain the Salvia miltiorrhiza extract; the obtained Salvia miltiorrhiza extract was concentrated to 400L, adjust the pH to 4.6 with hydrochloric acid solution, heat to 120 ° C for 3h, then cool to room temperature, filter, the filtrate is separated by 1400 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution, and then remove impurities.
  • the eluate containing salvianolic acid A was collected by elution with a volume fraction of 50% aqueous ethanol solution, concentrated to an alcohol-free taste, and then separated by a polyamide chromatography column, and then eluted with water and a 35% aqueous solution of ethanol. After eluting with a 75% aqueous solution of ethanol, the eluate containing salvianolic acid A was collected, concentrated to an alcohol-free taste, adjusted to pH 3.0 with magnesium hydrogencarbonate solution, extracted with butyl acetate, and concentrated. , dried, to obtain salvianolic acid A 797g, the content of 93.50%.
  • Salvia miltiorrhiza extract 200 kg of raw material Danshen and 1600 L of 70% ethanol solution of ethanol were mixed, and extracted at 80 ° C for 2 h. The filtrate was collected by filtration, and the residue was re-extracted 3 times. The obtained filtrate was combined to obtain Salvia miltiorrhiza extract.
  • the obtained Salvia miltiorrhiza extract was concentrated to 600L, adjust the pH to 3.5 with hydrochloric acid, heat to 120 ° C for 3.5h, then cool to room temperature, filter, the filtrate is separated by 1400 macroporous resin column chromatography, first elution with water, volume fraction of 20% ethanol solution, The eluate containing salvianolic acid A was collected and eluted with a 50% aqueous solution of ethanol.
  • the mixture was concentrated to an alcohol-free atmosphere and then separated on a polyamide column.
  • the mixture was eluted with water and a 35% aqueous solution of ethanol. Then, eluting with a 70% aqueous solution of ethanol, collecting the eluate containing salvianolic acid A, concentrating to an alcohol-free taste, adjusting the pH to 3.0 with sodium hydrogen carbonate solution, extracting with ethyl acetate, and extracting the solution Concentrated and dried to obtain 903 g of salvianolic acid A with a content of 91%.
  • Salvia miltiorrhiza extract 200 kg of raw material Salvia miltiorrhiza and 2400 L of a 90% ethanol aqueous solution were mixed, and extracted at 78 ° C for 3 h. The filtrate was collected by filtration, and the residue was twice extracted. The obtained filtrate was combined to obtain Salvia miltiorrhiza extract.
  • the obtained Salvia miltiorrhiza extract was concentrated to 800L, adjust the pH to 4.5 with nitric acid solution, heat to 130 ° C for 1 h, then cool to room temperature, filter, filtrate and 1300-I macroporous resin column chromatography, first elute with water, volume fraction of 30% ethanol solution Then, elute with a 70% aqueous solution of ethanol, collect the eluate containing salvianolic acid A, concentrate to an alcohol-free taste, and continue to separate the polyamide column, first elute with water, volume fraction of 50% ethanol solution.
  • the raw material Danshen 200kg and water 1200L were mixed, extracted at 100 ° C for 1 h, the filtrate was collected by filtration, and the filter residue was re-extracted once, and the obtained filtrate was combined to obtain Salvia miltiorrhiza extract; the obtained Salvia miltiorrhiza extract was concentrated to 400 L, and adjusted with nitric acid solution.
  • the eluate containing salvianolic acid A was collected, concentrated to an alcohol-free taste, adjusted to pH 5.0 with sodium hydroxide solution, extracted with propyl acetate, and the extract was concentrated and dried to obtain Salvianolic acid A 495g, content 63%.
  • Salvia miltiorrhiza extract 250 kg of raw salvia miltiorrhiza and 2000 L of aqueous solution of 60% by volume were mixed and extracted at 81 ° C for 3 h. The filtrate was collected by filtration, and the residue was twice extracted. The obtained filtrate was combined to obtain Salvia miltiorrhiza extract.
  • the obtained Salvia miltiorrhiza extract was concentrated to 645L, adjust the pH to 4.5 with nitric acid solution, heat to 120 ° C for 3h, then cool to room temperature, filter, the filtrate is separated by 1400 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution, and then remove impurities.
  • the eluate containing salvianolic acid A was collected by elution with a volume fraction of 40% aqueous solution of ethanol, concentrated to an alcohol-free taste, and then separated by a polyamide chromatography column, and then eluted with water and a 40% aqueous solution of ethanol.
  • the eluate containing salvianolic acid A was collected by elution with a volume fraction of 80% aqueous ethanol solution, concentrated to an alcohol-free taste, adjusted to pH 3.2 with sodium bicarbonate solution, extracted with ethyl acetate, and concentrated. , dried, to obtain salvianolic acid A 1260g, content 95.8%.
  • Salvia miltiorrhiza extract 250 kg of raw salvia miltiorrhiza and 2000 L of aqueous solution of 60% by volume were mixed and extracted at 81 ° C for 3 h. The filtrate was collected by filtration, and the residue was twice extracted. The obtained filtrate was combined to obtain Salvia miltiorrhiza extract.
  • the obtained Salvia miltiorrhiza extract was concentrated to 638L, adjust the pH to 4.6 with nitric acid solution, heat to 120 ° C for 3h, then cool to room temperature, filter, the filtrate is separated by 1400 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution, and then remove impurities.
  • the eluate containing salvianolic acid A was collected by elution with a volume fraction of 40% aqueous solution of ethanol, concentrated to an alcohol-free taste, and then separated by a polyamide chromatography column, and then eluted with water and a 40% aqueous solution of ethanol.
  • the eluate containing salvianolic acid A was collected by elution with a volume fraction of 80% aqueous ethanol solution, concentrated to an alcohol-free taste, adjusted to pH 3.2 with sodium bicarbonate solution, extracted with ethyl acetate, and concentrated. , dried, to obtain salvianolic acid A 1600g, the content of 98.2%.
  • Salvia miltiorrhiza extract 250 kg of raw salvia miltiorrhiza and 2000 L of aqueous solution of 60% by volume were mixed and extracted at 81 ° C for 3 h. The filtrate was collected by filtration, and the residue was twice extracted. The obtained filtrate was combined to obtain Salvia miltiorrhiza extract.
  • the obtained Salvia miltiorrhiza extract was concentrated to 635L, adjust the pH to 4.6 with nitric acid solution, heat to 120 ° C for 3h, then cool to room temperature, filter, the filtrate is separated by 1400 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution, and then remove impurities.
  • the eluate containing salvianolic acid A was collected by elution with a volume fraction of 40% aqueous solution of ethanol, concentrated to an alcohol-free taste, and then separated by a polyamide chromatography column, and then eluted with water and a 40% aqueous solution of ethanol.
  • the eluate containing salvianolic acid A was collected by elution with a volume fraction of 80% aqueous ethanol solution, concentrated to an alcohol-free taste, adjusted to pH 3.2 with sodium bicarbonate solution, extracted with ethyl acetate, and concentrated. , dried, to obtain salvianolic acid A 1554g, the content of 98.5%.
  • Examples 10 to 24 are preparation examples of salvianolic acid A salt.
  • the 600 mg of salvianolic acid A prepared in Example 1 was dissolved in 2400 mL of water at a weight ratio of 2:8, filtered, and the pH was adjusted to 1.2 by adding 5% sodium carbonate solution, and the precipitate was collected and dried under normal reduced pressure.
  • the salvianolic acid A sodium salt was 336 g, and the purity was 99.90%.
  • salvianolic acid A prepared in Example 2, dissolve it in 1400 mL of water at a weight ratio of 3:7, filter, add 15% sodium hydroxide solution to adjust the pH to 1.8, treat with activated carbon, filter, collect precipitates, reduce Press dry to obtain 343 g of salvianolic acid A sodium salt with a purity of 99.50%.
  • the 600 mg of salvianolic acid A prepared in Example 3 was dissolved in 900 mL of water at a weight ratio of 4:6, and the pH was adjusted to 1.5 by adding 1% sodium tartrate solution, activated carbon, filtered, and the precipitate was collected and dried under reduced pressure.
  • the salvianolic acid A sodium salt was 343 g, and the purity was 99.50%.
  • Example 5 100 g of salvianolic acid A prepared in Example 5 was dissolved in 100 mL of water at a weight ratio of 5:5, and the pH was adjusted to 3.5 by adding 5% magnesium hydrogencarbonate solution, and the precipitate was collected by filtration and dried under reduced pressure.
  • the phenolic acid A magnesium salt was 51 g, and the purity was 97.20%.
  • the purity of salvianolic acid A salt was obtained at different pH values for different purity raw materials, as shown in Table 1.
  • the different purity raw materials, salvianolic acid A, are dissolved in water, and an alkali solution is added to adjust different pH values, and the precipitates are collected to obtain salicylic acid A salt.
  • the raw material salvianolic acid A is dissolved in different proportions of water, and the pH is adjusted to 3.6 by adding an alkali solution, and the precipitate is dried to obtain salicylic acid A salt.
  • Example 10 The salicylic acid A salt of Example 10 was prepared from Example 1 and the salicylic acid A salt of Example 11 was prepared from Example 2 salvianolic acid A, and was prepared from Example 3 salvianolic acid A.
  • Example 12 salicylic acid A salt; from the data in the table, the content of salvianolic acid A decreased from about 93% to about 75% after one year of storage, and the impurity increased from 4% to 9%, and the salvianolic acid A was prepared. After the salt, there is no change before and after the placement, so it is quite stable after the salt is formed.
  • Example 10 The salicylic acid A salt of Example 10 was prepared from the salicylic acid A of Example 1. From the experimental data of high temperature, high humidity and strong light, it was found that the salt was more stable after salt formation.
  • Salvianolic acid A example Salvianolic acid A Water soluble Salvianolic acid A salt example Salvianolic acid A sodium salt Water soluble 6 63% Very soluble 16 92.1% Slightly soluble 5 84% Very soluble 17 97.2% Slightly soluble 4 91% Very soluble 18 98.6% Slightly soluble
  • 1 to 4 are respectively high-resolution mass spectrometry, 1 H NMR spectrum, 13 C NMR spectrum, and HMQC spectrum of salvianolic acid A sodium salt prepared by the present invention.
  • Test equipment Qstar Elite (Applietl Biosyhtems/MBS Sclex)
  • High-resolution mass spectrometry uses the ESI + ion mode, so the high-resolution mass spectrometry results in a molecular formula that is one more hydrogen than the sample formula.
  • the results of high-resolution mass spectrometry showed that there was a sodium ion in the molecule, indicating that salvianolic acid A exists in the form of sodium salt, and the salvianolic acid A and sodium ion in this product are 1:1 salt.
  • the low field region ⁇ 6.2 ⁇ 7.9, contains a total of 12 protons, 4 of which are hydrogen protons on the trans-olefin hydrogen, and the remaining 8 are aromatic ring hydrogen protons, which are completely consistent with the molecular structure.
  • the nuclear magnetic resonance spectrum data showed that the nuclear magnetic resonance spectrum of salvianolic acid A sodium was basically consistent with the nuclear magnetic resonance spectrum of salvianolic acid A, and the displacement of some hydrogen protons was slightly shifted.
  • the low field region, ⁇ 172.31, is the carbonyl carbon at the B9 position in the carboxylate; ⁇ 166.43, which is the carbonyl carbon at the A9 position in the ester group.
  • a carbon atom having a chemical shift at ⁇ 113 to 148 is an aromatic ring carbon atom or an olefin carbon atom.
  • the chemical shift of the unsubstituted carbon atom on the benzene ring is ⁇ 113-121, and the carbon atom having a chemical shift of ⁇ 143-147 is a carbon atom connected to the hydroxyl group on the benzene ring.
  • ⁇ 119.24, containing 2 carbon atoms, is associated with 2 aromatic hydrogens in the HMQC correlation diagram.
  • the nuclear magnetic carbon spectrum data showed that the carbon spectrum of salvianolic acid A sodium salt compared with the carbon spectrum of salvianolic acid A, the chemical shift of carbonyl carbon B9 and its attached B8 carbon shifted slightly to the low field, and the displacement of other carbon atoms was basically the same.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Provided in the present invention is a method for preparing a salvianolic acid A salt, the preparation method being: dissolving salvianolic acid A in water, then adjusting the pH value to be 1.2-5.5 by using an aqueous solution of a basic substance, and collecting a precipitate, i.e., a salvianolic acid A salt; the present invention uses a method of adding a basic solution to a salvianolic acid A aqueous solution to increase the pH value and precipitate a salvianolic acid A salt, thereby preparing and obtaining a salvianolic acid A salt product which has strong stability, cannot be easily oxidized, has high purity and reduced impurities; said preparation method is efficient, simple and easy to implement, while being more suitable for industrial mass production, and being beneficial to the development and application of salvianolic acid A salt.

Description

一种丹酚酸A盐的制备方法Preparation method of salvianolic acid A salt (一)技术领域(1) Technical field
本发明涉及一种丹酚酸A盐的制备方法。The invention relates to a preparation method of salvianolic acid A salt.
(二)背景技术(2) Background technology
丹酚酸A(Salvianicacid A)是唇形科植物丹参中所含的一种水溶性酚酸类化合物,最早是由黎莲娘教授于1984年从丹参中分离得到(LiLian-Niang,et al.PlantaMedica.1984,50:227)。丹酚酸A具有较强的心肌缺血保护、抗血栓形成、抗肝纤维化和抗氧化等药理活性,对心脑血管疾病具有潜在的治疗价值。Salvianic acid A (Salvianic acid A) is a water-soluble phenolic acid compound contained in Salvia miltiorrhiza. It was first isolated from Salvia miltiorrhiza in 1984 by Professor Li Lian Niang (LiLian-Niang, et al. Planta Medica. 1984, 50: 227). Salvianolic acid A has strong pharmacological activities such as myocardial ischemia protection, antithrombotic, anti-fibrosis and anti-oxidation, and has potential therapeutic value for cardiovascular and cerebrovascular diseases.
丹酚酸A存在易被氧化、稳定性差,制成各种剂型很难保证其长期稳定的问题。CN105523926 A公开了丹酚酸A的提取分离纯化方法及丹酚酸A盐的制备方法,其中采用了丹酚酸A镁盐络合法,但其得到的是含有氯化钠或氯化钾的镁盐络合物。CN102432467 B公开了一种丹酚酸A镁盐的制备方法,此制备方法存在工艺流程复杂,生产成本高,不适合工业化生产或制备等不足。The presence of salvianolic acid A is easily oxidized and has poor stability, and it is difficult to ensure long-term stability in various dosage forms. CN105523926 A discloses a method for extracting and separating and purifying salvianolic acid A and a method for preparing salvianolic acid A salt, wherein a magnesium salt of salvianolic acid A is used, but the obtained method comprises sodium chloride or potassium chloride. Magnesium salt complex. CN102432467 B discloses a preparation method of salvianolic acid A magnesium salt, which has the advantages of complicated process flow, high production cost, and is not suitable for industrial production or preparation.
(三)发明内容(3) Invention content
本发明的目的在于提供一种稳定性强,不易被氧化,纯度高的丹酚酸A盐的制备方法,本发明制备方法具有工艺性好,操作简单,生产成本低,适于工业化生产或制备的特点。The object of the present invention is to provide a preparation method of salvianolic acid A salt which has high stability, is not easily oxidized, and has high purity. The preparation method has the advantages of good processability, simple operation, low production cost, and is suitable for industrial production or preparation. specialty.
本发明采用如下技术方案:The invention adopts the following technical solutions:
一种丹酚酸A盐的制备方法,所述的制备方法为:A method for preparing salvianolic acid A salt, wherein the preparation method is:
取丹酚酸A溶解于水中,再用碱性物质的水溶液调节pH值为1.2~5.5(优选3.2~4.2),收集析出物,即为所述的丹酚酸A盐。The salvianolic acid A is dissolved in water, and the pH is adjusted to a pH of 1.2 to 5.5 (preferably 3.2 to 4.2) with an aqueous solution of an alkaline substance, and the precipitate is collected to be the salvianolic acid A salt.
本发明所述的制备方法中,所述丹酚酸A与水的料液质量比为1:0.25~4,优选1:0.67~1.5。In the preparation method of the present invention, the mass ratio of the salicylic acid A to water is 1:0.25 to 4, preferably 1:0.67 to 1.5.
所述碱性物质的水溶液的浓度为1%~15%,优选4%~11%;所述的碱性物质包括强碱、弱酸强碱盐,具体例如:氢氧化钠、碳酸氢钠、碳酸钠、氢氧化钾、碳酸氢钾、碳酸钾、氢氧化镁、碳酸氢镁、碳酸镁、氢氧化钙、碳酸氢钙、碳酸钙、柠檬酸钠、酒石酸钠、柠檬酸钾、酒石酸钾、柠檬酸镁或酒石酸镁。The concentration of the aqueous solution of the alkaline substance is 1% to 15%, preferably 4% to 11%; the alkaline substance includes a strong base, a weak acid strong base salt, specifically, for example, sodium hydroxide, sodium hydrogencarbonate, carbonic acid Sodium, potassium hydroxide, potassium hydrogencarbonate, potassium carbonate, magnesium hydroxide, magnesium hydrogencarbonate, magnesium carbonate, calcium hydroxide, calcium hydrogencarbonate, calcium carbonate, sodium citrate, sodium tartrate, potassium citrate, potassium tartrate, lemon Magnesium or magnesium tartrate.
本发明制得的丹酚酸A盐为丹酚酸A的钠盐、钾盐、镁盐或钙盐。The salvianolic acid A salt obtained by the present invention is a sodium salt, a potassium salt, a magnesium salt or a calcium salt of salvianolic acid A.
所述制备方法中,收集所得的析出物用水清洗、干燥后,即可直接用于制剂或与人体可接受的药用辅料一起用于制剂。In the preparation method, the collected precipitates are washed with water and dried, and then directly used in the preparation or used together with a human acceptable pharmaceutical excipient for the preparation.
本发明所述的丹酚酸A由原料丹参经水或乙醇水溶液提取、大孔树脂柱层析分离、聚酰胺层析柱分离制备而得。其制备方法例如可参考:中国专利CN101361728 B公开的方法。The salvianolic acid A of the invention is obtained by extracting raw material Danshen by water or ethanol aqueous solution, separating by macroporous resin column chromatography and separating by polyamide chromatography column. For the preparation method, for example, the method disclosed in Chinese Patent No. CN101361728 B can be referred to.
具体的,所述丹酚酸A的制备方法通常为:Specifically, the preparation method of the salvianolic acid A is generally:
(1)将原料丹参按料液质量比1:6~12与水或体积分数10%~90%的乙醇水溶液混合,在70~100℃下提取1~3h,过滤收集滤液,滤渣复提1~3次,合并各次所得滤液,得到丹参提取液;(1) Mixing the raw material Danshen according to the mass ratio of the liquid: 1:6~12 with water or volume fraction of 10%-90% ethanol solution, extracting at 70-100 °C for 1-3 hours, collecting the filtrate by filtration, and extracting the residue. ~3 times, combining the filtrates obtained each time to obtain the extract of Salvia miltiorrhiza;
(2)取步骤(1)所得丹参提取液,浓缩(通常浓缩至原料丹参质量的2~4倍),调节pH至3.5~6.0(常规操作,用无机酸的水溶液进行调节,所述的无机酸例如盐酸、硫酸、硝酸等),升温至110~130℃加热1~6h,之后冷却至室温(20~30℃),过滤,滤液进行大孔树脂柱层析分离,先用水、体积分数10%~30%乙醇水溶液洗脱除杂,再用体积分数30%~70%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩(至无醇味)后继续进行聚酰胺层析柱分离,先用水、体积分数20%~50%乙醇水溶液洗脱除杂,再用体积分数50%~95%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩(至无醇味)后调pH值至2~5(常规操作,用碱性物质的水溶液进行调节,所述的碱性物质如上述所定义),经有机溶剂萃取,萃取液经浓缩,干燥,即得所述的丹酚酸A;(2) taking the salvia miltiorrhiza extract obtained in the step (1), concentrating (usually concentrated to 2 to 4 times the mass of the raw salvia miltiorrhiza), and adjusting the pH to 3.5 to 6.0 (normal operation, adjustment with an aqueous solution of a mineral acid, the inorganic Acids such as hydrochloric acid, sulfuric acid, nitric acid, etc., are heated to 110-130 ° C for 1 to 6 hours, then cooled to room temperature (20 ~ 30 ° C), filtered, and the filtrate is separated by macroporous resin column chromatography, first with water, volume fraction 10 After elution with %~30% ethanol aqueous solution, elute with 30%-70% ethanol aqueous solution, collect eluate containing salvianolic acid A, concentrate (to no alcohol taste) and continue polyamide chromatography Separation of the column, first elution with water, volume fraction of 20% ~ 50% ethanol aqueous solution, and then eluted with a volume fraction of 50% ~ 95% ethanol aqueous solution, collecting eluate containing salvianolic acid A, concentrated (to alcohol-free Taste) adjust the pH to 2 to 5 (conventional operation, adjusted with an aqueous solution of a basic substance, the basic substance is as defined above), extracted with an organic solvent, and the extract is concentrated and dried to obtain Salvianolic acid A;
所述的原料丹参为唇形科植物丹参Salvia miltiorrhiza Bge.的干燥根和根茎,可在市面上常规商购获得;The raw material Salvia miltiorrhiza is the dried root and rhizome of Salvia miltiorrhiza Bge., which is commercially available on the market;
所述的大孔树脂为HPD-100、HPD-100A、HPD-300、HPD-400、HPD-400A、HPD-450、D101、1300-I、1400或AB-8;The macroporous resin is HPD-100, HPD-100A, HPD-300, HPD-400, HPD-400A, HPD-450, D101, 1300-I, 1400 or AB-8;
所述用于萃取的有机溶剂为乙酸乙酯、乙酸丙酯、乙酸丁酯、正丁醇或异丙醇;The organic solvent used for the extraction is ethyl acetate, propyl acetate, butyl acetate, n-butanol or isopropanol;
制得的丹酚酸A纯度为50%~100%,可直接用于后续丹酚酸A盐的制备。The obtained salvianolic acid A has a purity of 50% to 100%, and can be directly used for the preparation of the subsequent salvianolic acid A salt.
本发明的有益效果在于:本发明采用在丹酚酸A水溶液中加碱溶液提高pH,析出丹酚酸A盐的方法,制备得到了稳定性强,不易被氧化,纯度高,杂质下降的丹酚酸A盐产品。此制备方法简单,更适合于工业化大生产。因此,本发明为丹酚酸A盐的制备提供了一种高效且简单易行的方法,有利于丹酚酸A盐开发和应用。The invention has the beneficial effects that the invention adopts a method for increasing the pH and extracting the salvianolic acid A salt by adding an alkali solution in the aqueous solution of salvianolic acid A, and preparing a method which has strong stability, is not easily oxidized, has high purity, and has reduced impurities. Phenolic acid A salt product. The preparation method is simple and more suitable for industrial large production. Therefore, the present invention provides an efficient and simple method for the preparation of salvianolic acid A salt, which is beneficial to the development and application of salvianolic acid A salt.
(四)附图说明(4) Description of the drawings
图1:丹酚酸A钠盐的高分辨质谱;Figure 1: High resolution mass spectrum of salvianolic acid A sodium salt;
图2:丹酚酸A钠盐的 1H NMR谱; Figure 2: 1 H NMR spectrum of salvianolic acid A sodium salt;
图3:丹酚酸A钠盐的 13C NMR谱; Figure 3: 13 C NMR spectrum of salvianolic acid A sodium salt;
图4:丹酚酸A钠盐的HMQC谱。Figure 4: HMQC spectrum of salvianolic acid A sodium salt.
(五)具体实施方式(5) Specific implementation methods
下面通过具体实施例对本发明作进一步的说明,但本发明的保护范围并不仅限于此。The present invention will be further illustrated by the following specific examples, but the scope of the present invention is not limited thereto.
实施例1~9为丹酚酸A的制备实施例,参考CN 101361728 B公开的方法。原料丹参购自上海华宇药业有限公司。Examples 1 to 9 are preparation examples of salvianolic acid A, and refer to the method disclosed in CN 101361728 B. Raw material Danshen was purchased from Shanghai Huayu Pharmaceutical Co., Ltd.
实施例1Example 1
将原料丹参200kg与体积分数50%的乙醇水溶液2000L混合,在82℃下提取2h,过滤收集滤液,滤渣复提3次,合并各次所得滤液,得到丹参提取液;将所得丹参提取液浓缩至600L,用盐酸液调节pH至4.5,升温至120℃加热4h,之后冷却至室温,过滤,滤液进行HPD-100大孔树脂柱层析分离,先用水、体积分数20%乙醇水溶液洗脱除杂,再用体积分数50%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后继续进行聚酰胺层析柱分离,先用水、体积分数35%乙醇水溶液洗脱除杂,再用体积分数75%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后,用碳酸氢钾溶液调pH值至3.0,经乙酸乙酯萃取,萃取液经浓缩,干燥, 得到丹酚酸A 816g,含量93.20%。The raw material Danshen 200kg and the volume fraction 50% ethanol aqueous solution 2000L were mixed, extracted at 82 ° C for 2h, the filtrate was collected by filtration, the filter residue was re-extracted 3 times, and the obtained filtrate was combined to obtain Salvia miltiorrhiza extract; the obtained Salvia miltiorrhiza extract was concentrated to 600L, adjust the pH to 4.5 with hydrochloric acid, heat to 120 ° C for 4h, then cool to room temperature, filter, filtrate for HPD-100 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution Then, elute with a 50% aqueous solution of ethanol, collect the eluate containing salvianolic acid A, concentrate to an alcohol-free taste, and continue to separate the polyamide column, first elute with water and a volume fraction of 35% ethanol solution. Miscellaneous, and eluted with 75% aqueous solution of ethanol, collected the eluate containing salvianolic acid A, concentrated to an alcohol-free taste, adjusted to pH 3.0 with potassium bicarbonate solution, extracted with ethyl acetate, extract After concentration and drying, salvianolic acid A 816g was obtained in an amount of 93.20%.
实施例2Example 2
将原料丹参200kg与体积分数50%的乙醇水溶液2000L混合,在82℃下提取2h,过滤收集滤液,滤渣复提2次,合并各次所得滤液,得到丹参提取液;将所得丹参提取液浓缩至400L,用盐酸液调节pH至4.4,升温至120℃加热2.5h,之后冷却至室温,过滤,滤液进行HPD-300大孔树脂柱层析分离,先用水、体积分数20%乙醇水溶液洗脱除杂,再用体积分数50%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后继续进行聚酰胺层析柱分离,先用水、体积分数35%乙醇水溶液洗脱除杂,再用体积分数75%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后,用碳酸钾溶液调pH值至3.0,经乙酸丙酯萃取,萃取液经浓缩,干燥,得到丹酚酸A 808g,含量93.80%。The raw material Danshen 200kg and the volume fraction 50% ethanol aqueous solution 2000L were mixed, extracted at 82 ° C for 2h, the filtrate was collected by filtration, the filter residue was double-recovered twice, and the obtained filtrate was combined to obtain the Salvia miltiorrhiza extract; the obtained Salvia miltiorrhiza extract was concentrated to 400L, adjust the pH to 4.4 with hydrochloric acid solution, heat to 120 ° C for 2.5h, then cool to room temperature, filter, filtrate for HPD-300 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution Miscellaneous, and then eluted with a 50% aqueous solution of ethanol, collected eluate containing salvianolic acid A, concentrated to an alcohol-free taste, and then separated on a polyamide column, first eluted with water, a volume fraction of 35% ethanol After removing impurities, elute with a 75% aqueous solution of ethanol, collect the eluate containing salvianolic acid A, concentrate to an alcohol-free taste, adjust the pH to 3.0 with potassium carbonate solution, extract with propyl acetate, extract After concentration and drying, salvianolic acid A 808 g was obtained in an amount of 93.80%.
实施例3Example 3
将原料丹参200kg与体积分数50%的乙醇水溶液2000L混合,在82℃下提取2h,过滤收集滤液,滤渣复提2次,合并各次所得滤液,得到丹参提取液;将所得丹参提取液浓缩至400L,用盐酸液调节pH至4.6,升温至120℃加热3h,之后冷却至室温,过滤,滤液进行1400大孔树脂柱层析分离,先用水、体积分数20%乙醇水溶液洗脱除杂,再用体积分数50%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后继续进行聚酰胺层析柱分离,先用水、体积分数35%乙醇水溶液洗脱除杂,再用体积分数75%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后,用碳酸氢镁溶液调pH值至3.0,经乙酸丁酯萃取,萃取液经浓缩,干燥,得到丹酚酸A 797g,含量93.50%。The raw material Danshen 200kg and the volume fraction 50% ethanol aqueous solution 2000L were mixed, extracted at 82 ° C for 2h, the filtrate was collected by filtration, the filter residue was double-recovered twice, and the obtained filtrate was combined to obtain the Salvia miltiorrhiza extract; the obtained Salvia miltiorrhiza extract was concentrated to 400L, adjust the pH to 4.6 with hydrochloric acid solution, heat to 120 ° C for 3h, then cool to room temperature, filter, the filtrate is separated by 1400 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution, and then remove impurities. The eluate containing salvianolic acid A was collected by elution with a volume fraction of 50% aqueous ethanol solution, concentrated to an alcohol-free taste, and then separated by a polyamide chromatography column, and then eluted with water and a 35% aqueous solution of ethanol. After eluting with a 75% aqueous solution of ethanol, the eluate containing salvianolic acid A was collected, concentrated to an alcohol-free taste, adjusted to pH 3.0 with magnesium hydrogencarbonate solution, extracted with butyl acetate, and concentrated. , dried, to obtain salvianolic acid A 797g, the content of 93.50%.
实施例4Example 4
将原料丹参200kg与体积分数70%的乙醇水溶液1600L混合,在80℃下提取2h,过滤收集滤液,滤渣复提3次,合并各次所得滤液,得到丹参提取液;将所得丹参提取液浓缩至600L,用盐酸液调节pH至3.5,升温至120℃加热3.5h,之后冷却至室温,过滤,滤液进行1400大孔树脂柱层析分离,先用水、体积分数20%乙醇水溶液洗脱除杂,再用体积分数50%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后继续进行聚酰胺层析柱分离,先用水、体积分数35%乙醇水溶液洗脱除杂,再用体积分数70%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后,用碳酸氢钠溶液调pH值至3.0,经乙酸乙酯萃取,萃取液经浓缩,干燥,得到丹酚酸A 903g,含量91%。200 kg of raw material Danshen and 1600 L of 70% ethanol solution of ethanol were mixed, and extracted at 80 ° C for 2 h. The filtrate was collected by filtration, and the residue was re-extracted 3 times. The obtained filtrate was combined to obtain Salvia miltiorrhiza extract. The obtained Salvia miltiorrhiza extract was concentrated to 600L, adjust the pH to 3.5 with hydrochloric acid, heat to 120 ° C for 3.5h, then cool to room temperature, filter, the filtrate is separated by 1400 macroporous resin column chromatography, first elution with water, volume fraction of 20% ethanol solution, The eluate containing salvianolic acid A was collected and eluted with a 50% aqueous solution of ethanol. The mixture was concentrated to an alcohol-free atmosphere and then separated on a polyamide column. The mixture was eluted with water and a 35% aqueous solution of ethanol. Then, eluting with a 70% aqueous solution of ethanol, collecting the eluate containing salvianolic acid A, concentrating to an alcohol-free taste, adjusting the pH to 3.0 with sodium hydrogen carbonate solution, extracting with ethyl acetate, and extracting the solution Concentrated and dried to obtain 903 g of salvianolic acid A with a content of 91%.
实施例5Example 5
将原料丹参200kg与体积分数90%的乙醇水溶液2400L混合,在78℃下提取3h,过滤收集滤液,滤渣复提2次,合并各次所得滤液,得到丹参提取液;将所得丹参提取液浓缩至800L,用硝酸溶液调节pH至4.5,升温至130℃加热1h,之后冷却至室温,过滤,滤液进行1300-I大孔树脂柱层析分离,先用水、体积分数30%乙醇水溶液洗脱除杂,再用体积分数70%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后继续进行聚酰胺层析柱分离,先用水、体积分数50%乙醇水溶液洗脱除杂,再用体积分数95%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后,用碳酸钠溶液调pH值至2.0,经乙酸丁酯萃取,萃取液经浓缩,干燥,得到丹酚酸A 711g,含量84%。200 kg of raw material Salvia miltiorrhiza and 2400 L of a 90% ethanol aqueous solution were mixed, and extracted at 78 ° C for 3 h. The filtrate was collected by filtration, and the residue was twice extracted. The obtained filtrate was combined to obtain Salvia miltiorrhiza extract. The obtained Salvia miltiorrhiza extract was concentrated to 800L, adjust the pH to 4.5 with nitric acid solution, heat to 130 ° C for 1 h, then cool to room temperature, filter, filtrate and 1300-I macroporous resin column chromatography, first elute with water, volume fraction of 30% ethanol solution Then, elute with a 70% aqueous solution of ethanol, collect the eluate containing salvianolic acid A, concentrate to an alcohol-free taste, and continue to separate the polyamide column, first elute with water, volume fraction of 50% ethanol solution. Miscellaneous, and then eluted with 95% aqueous solution of ethanol, collected eluate containing salvianolic acid A, concentrated to an alcohol-free taste, adjusted to pH 2.0 with sodium carbonate solution, extracted with butyl acetate, the extract was Concentrated and dried to obtain salvianolic acid A 711 g, content 84%.
实施例6Example 6
将原料丹参200kg与水1200L混合,在100℃下提取1h,过滤收集滤液,滤渣复提1次,合 并各次所得滤液,得到丹参提取液;将所得丹参提取液浓缩至400L,用硝酸溶液调节pH至6,升温至110℃加热6h,之后冷却至室温,过滤,滤液进行AB-8大孔树脂柱层析分离,先用水、体积分数10%乙醇水溶液洗脱除杂,再用体积分数30%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后继续进行聚酰胺层析柱分离,先用水、体积分数20%乙醇水溶液洗脱除杂,再用体积分数50%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后,用氢氧化钠溶液调pH值至5.0,经乙酸丙酯萃取,萃取液经浓缩,干燥,得到丹酚酸A 495g,含量63%。The raw material Danshen 200kg and water 1200L were mixed, extracted at 100 ° C for 1 h, the filtrate was collected by filtration, and the filter residue was re-extracted once, and the obtained filtrate was combined to obtain Salvia miltiorrhiza extract; the obtained Salvia miltiorrhiza extract was concentrated to 400 L, and adjusted with nitric acid solution. pH to 6, warmed to 110 ° C for 6h, then cooled to room temperature, filtered, the filtrate was separated by AB-8 macroporous resin column chromatography, first eluted with water, volume fraction of 10% ethanol solution, and then used to volume fraction 30 After elution with % ethanol solution, the eluate containing salvianolic acid A was collected, concentrated to an alcohol-free taste, and then separated by polyamide chromatography column, first eluted with water, volume fraction of 20% aqueous ethanol solution, and then used for volume fraction. After elution with 50% ethanol aqueous solution, the eluate containing salvianolic acid A was collected, concentrated to an alcohol-free taste, adjusted to pH 5.0 with sodium hydroxide solution, extracted with propyl acetate, and the extract was concentrated and dried to obtain Salvianolic acid A 495g, content 63%.
实施例7Example 7
将原料丹参250kg与体积分数60%的乙醇水溶液2000L混合,在81℃下提取3h,过滤收集滤液,滤渣复提2次,合并各次所得滤液,得到丹参提取液;将所得丹参提取液浓缩至645L,用硝酸溶液调节pH至4.5,升温至120℃加热3h,之后冷却至室温,过滤,滤液进行1400大孔树脂柱层析分离,先用水、体积分数20%乙醇水溶液洗脱除杂,再用体积分数40%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后继续进行聚酰胺层析柱分离,先用水、体积分数40%乙醇水溶液洗脱除杂,再用体积分数80%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后,用碳酸氢钠溶液调pH值至3.2,经乙酸乙酯萃取,萃取液经浓缩,干燥,得到丹酚酸A 1260g,含量95.8%。250 kg of raw salvia miltiorrhiza and 2000 L of aqueous solution of 60% by volume were mixed and extracted at 81 ° C for 3 h. The filtrate was collected by filtration, and the residue was twice extracted. The obtained filtrate was combined to obtain Salvia miltiorrhiza extract. The obtained Salvia miltiorrhiza extract was concentrated to 645L, adjust the pH to 4.5 with nitric acid solution, heat to 120 ° C for 3h, then cool to room temperature, filter, the filtrate is separated by 1400 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution, and then remove impurities. The eluate containing salvianolic acid A was collected by elution with a volume fraction of 40% aqueous solution of ethanol, concentrated to an alcohol-free taste, and then separated by a polyamide chromatography column, and then eluted with water and a 40% aqueous solution of ethanol. The eluate containing salvianolic acid A was collected by elution with a volume fraction of 80% aqueous ethanol solution, concentrated to an alcohol-free taste, adjusted to pH 3.2 with sodium bicarbonate solution, extracted with ethyl acetate, and concentrated. , dried, to obtain salvianolic acid A 1260g, content 95.8%.
实施例8Example 8
将原料丹参250kg与体积分数60%的乙醇水溶液2000L混合,在81℃下提取3h,过滤收集滤液,滤渣复提2次,合并各次所得滤液,得到丹参提取液;将所得丹参提取液浓缩至638L,用硝酸溶液调节pH至4.6,升温至120℃加热3h,之后冷却至室温,过滤,滤液进行1400大孔树脂柱层析分离,先用水、体积分数20%乙醇水溶液洗脱除杂,再用体积分数40%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后继续进行聚酰胺层析柱分离,先用水、体积分数40%乙醇水溶液洗脱除杂,再用体积分数80%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后,用碳酸氢钠溶液调pH值至3.2,经乙酸乙酯萃取,萃取液经浓缩,干燥,得到丹酚酸A 1600g,含量98.2%。250 kg of raw salvia miltiorrhiza and 2000 L of aqueous solution of 60% by volume were mixed and extracted at 81 ° C for 3 h. The filtrate was collected by filtration, and the residue was twice extracted. The obtained filtrate was combined to obtain Salvia miltiorrhiza extract. The obtained Salvia miltiorrhiza extract was concentrated to 638L, adjust the pH to 4.6 with nitric acid solution, heat to 120 ° C for 3h, then cool to room temperature, filter, the filtrate is separated by 1400 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution, and then remove impurities. The eluate containing salvianolic acid A was collected by elution with a volume fraction of 40% aqueous solution of ethanol, concentrated to an alcohol-free taste, and then separated by a polyamide chromatography column, and then eluted with water and a 40% aqueous solution of ethanol. The eluate containing salvianolic acid A was collected by elution with a volume fraction of 80% aqueous ethanol solution, concentrated to an alcohol-free taste, adjusted to pH 3.2 with sodium bicarbonate solution, extracted with ethyl acetate, and concentrated. , dried, to obtain salvianolic acid A 1600g, the content of 98.2%.
实施例9Example 9
将原料丹参250kg与体积分数60%的乙醇水溶液2000L混合,在81℃下提取3h,过滤收集滤液,滤渣复提2次,合并各次所得滤液,得到丹参提取液;将所得丹参提取液浓缩至635L,用硝酸溶液调节pH至4.6,升温至120℃加热3h,之后冷却至室温,过滤,滤液进行1400大孔树脂柱层析分离,先用水、体积分数20%乙醇水溶液洗脱除杂,再用体积分数40%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后继续进行聚酰胺层析柱分离,先用水、体积分数40%乙醇水溶液洗脱除杂,再用体积分数80%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩至无醇味后,用碳酸氢钠溶液调pH值至3.2,经乙酸乙酯萃取,萃取液经浓缩,干燥,得到丹酚酸A 1554g,含量98.5%。250 kg of raw salvia miltiorrhiza and 2000 L of aqueous solution of 60% by volume were mixed and extracted at 81 ° C for 3 h. The filtrate was collected by filtration, and the residue was twice extracted. The obtained filtrate was combined to obtain Salvia miltiorrhiza extract. The obtained Salvia miltiorrhiza extract was concentrated to 635L, adjust the pH to 4.6 with nitric acid solution, heat to 120 ° C for 3h, then cool to room temperature, filter, the filtrate is separated by 1400 macroporous resin column chromatography, first elute with water, volume fraction of 20% ethanol solution, and then remove impurities. The eluate containing salvianolic acid A was collected by elution with a volume fraction of 40% aqueous solution of ethanol, concentrated to an alcohol-free taste, and then separated by a polyamide chromatography column, and then eluted with water and a 40% aqueous solution of ethanol. The eluate containing salvianolic acid A was collected by elution with a volume fraction of 80% aqueous ethanol solution, concentrated to an alcohol-free taste, adjusted to pH 3.2 with sodium bicarbonate solution, extracted with ethyl acetate, and concentrated. , dried, to obtain salvianolic acid A 1554g, the content of 98.5%.
实施例10~24为丹酚酸A盐的制备实施例。Examples 10 to 24 are preparation examples of salvianolic acid A salt.
实施例10Example 10
取实施例1制备的丹酚酸A 600g,以2:8的重量体积比溶解于2400mL水中,过滤,加5%碳酸钠溶液调节pH值至1.2,过滤,收集析出物,常规减压干燥即得丹酚酸A钠盐336g,纯度 99.90%。The 600 mg of salvianolic acid A prepared in Example 1 was dissolved in 2400 mL of water at a weight ratio of 2:8, filtered, and the pH was adjusted to 1.2 by adding 5% sodium carbonate solution, and the precipitate was collected and dried under normal reduced pressure. The salvianolic acid A sodium salt was 336 g, and the purity was 99.90%.
实施例11Example 11
取实施例2制备的丹酚酸A 600g,以3:7的重量体积比溶解于1400mL水中,过滤,加15%氢氧化钠溶液调节pH值至1.8,活性炭处理,过滤,收集析出物,减压干燥即得丹酚酸A钠盐343g,纯度99.50%。Take 600 mg of salvianolic acid A prepared in Example 2, dissolve it in 1400 mL of water at a weight ratio of 3:7, filter, add 15% sodium hydroxide solution to adjust the pH to 1.8, treat with activated carbon, filter, collect precipitates, reduce Press dry to obtain 343 g of salvianolic acid A sodium salt with a purity of 99.50%.
实施例12Example 12
取实施例3制备的丹酚酸A 600g,以4:6的重量体积比溶解于900mL水中,加1%酒石酸钠溶液调节pH值至1.5,活性炭处理,过滤,收集析出物,减压干燥即得丹酚酸A钠盐343g,纯度99.50%。The 600 mg of salvianolic acid A prepared in Example 3 was dissolved in 900 mL of water at a weight ratio of 4:6, and the pH was adjusted to 1.5 by adding 1% sodium tartrate solution, activated carbon, filtered, and the precipitate was collected and dried under reduced pressure. The salvianolic acid A sodium salt was 343 g, and the purity was 99.50%.
实施例13Example 13
取实施例6制备的丹酚酸A 100g,以5:5的重量体积比溶解于100mL水中,加5%碳酸钠溶液调节pH值至1.2,过滤,收集析出物,减压干燥即得丹酚酸A钠盐34g,纯度91.10%。100 g of salvianolic acid A prepared in Example 6 was dissolved in 100 mL of water by weight ratio of 5:5, and the pH was adjusted to 1.2 by adding 5% sodium carbonate solution, and the precipitate was collected by filtration and dried under reduced pressure to obtain dansyl alcohol. Acid A sodium salt 34g, purity 91.10%.
实施例14Example 14
取实施例5制备的丹酚酸A 100g,以5:5的重量体积比溶解于100mL水中,加5%碳酸钠溶液调节pH值至1.2,过滤,收集析出物,减压干燥即得丹酚酸A钠盐47g,纯度97.70%。100 g of salvianolic acid A prepared in Example 5 was dissolved in 100 mL of water at a weight ratio of 5:5, and the pH was adjusted to 1.2 by adding 5% sodium carbonate solution, and the precipitate was collected by filtration and dried under reduced pressure to obtain dansyl alcohol. Acid A sodium salt 47g, purity 97.70%.
实施例15Example 15
取实施例4制备的丹酚酸A 100g,以5:5的重量体积比溶解于100mL水中,加5%碳酸钠溶液调节pH值至1.2,过滤,收集析出物,减压干燥即得丹酚酸A钠盐57g,纯度98.30%。100 g of salvianolic acid A prepared in Example 4 was dissolved in 100 mL of water by weight ratio of 5:5, and the pH was adjusted to 1.2 by adding 5% sodium carbonate solution, and the precipitate was collected by filtration and dried under reduced pressure to obtain dansyl alcohol. Acid A sodium salt 57g, purity 98.30%.
实施例16Example 16
取实施例6制备的丹酚酸A 100g,以5:5的重量体积比溶解于100mL水中,加5%碳酸氢镁溶液调节pH值至3.5,过滤,收集析出物,减压干燥即得丹酚酸A镁盐36g,纯度92.10%。100 g of salvianolic acid A prepared in Example 6 was dissolved in 100 mL of water at a weight ratio of 5:5, and the pH was adjusted to 3.5 by adding 5% magnesium hydrogencarbonate solution, and the precipitate was collected by filtration, and dried under reduced pressure. Phenolic acid A magnesium salt 36g, purity 92.10%.
实施例17Example 17
取实施例5制备的丹酚酸A 100g,以5:5的重量体积比溶解于100mL水中,加5%碳酸氢镁溶液调节pH值至3.5,过滤,收集析出物,减压干燥即得丹酚酸A镁盐51g,纯度97.20%。100 g of salvianolic acid A prepared in Example 5 was dissolved in 100 mL of water at a weight ratio of 5:5, and the pH was adjusted to 3.5 by adding 5% magnesium hydrogencarbonate solution, and the precipitate was collected by filtration and dried under reduced pressure. The phenolic acid A magnesium salt was 51 g, and the purity was 97.20%.
实施例18Example 18
取实施例4制备的丹酚酸A 100g,以5:5的重量体积比溶解于100mL水中,加5%碳酸氢镁溶液调节pH值至3.5,过滤,收集析出物,减压干燥即得丹酚酸A镁盐58g,纯度98.60%。100 g of salvianolic acid A prepared in Example 4 was dissolved in 100 mL of water by weight ratio of 5:5, and the pH was adjusted to 3.5 by adding 5% magnesium hydrogencarbonate solution, and the precipitate was collected by filtration and dried under reduced pressure. Phenolic acid A magnesium salt 58g, purity 98.60%.
实施例19Example 19
取实施例6制备的丹酚酸A 100g,以5:5的重量体积比溶解于100mL水中,加5%碳酸氢钾溶液调节pH值至5.5,过滤,收集析出物,减压干燥即得丹酚酸A钾盐39g,纯度90.40%。100 g of salvianolic acid A prepared in Example 6 was dissolved in 100 mL of water at a weight ratio of 5:5, and the pH was adjusted to 5.5 by adding 5% potassium hydrogencarbonate solution, and the precipitate was collected by filtration, and dried under reduced pressure. Phenolic acid A potassium salt 39g, purity 90.40%.
实施例20Example 20
取实施例5制备的丹酚酸A 100g,以5:5的重量体积比溶解于100mL水中,加5%碳酸氢钾溶液调节pH值至5.5,过滤,收集析出物,减压干燥即得丹酚酸A钾盐52g,纯度96.80%。100 g of salvianolic acid A prepared in Example 5 was dissolved in 100 mL of water at a weight ratio of 5:5, and the pH was adjusted to 5.5 by adding 5% potassium hydrogencarbonate solution, and the precipitate was collected by filtration, and dried under reduced pressure. Phenolic acid A potassium salt 52g, purity 96.80%.
实施例21Example 21
取实施例4制备的丹酚酸A 100g,以5:5的重量体积比溶解于100mL水中,加5%碳酸氢钾溶液调节pH值至5.5,过滤,收集析出物,减压干燥即得丹酚酸A钾盐58g,纯度97.50%。100 g of salvianolic acid A prepared in Example 4 was dissolved in 100 mL of water at a weight ratio of 5:5, and the pH was adjusted to 5.5 by adding 5% potassium hydrogencarbonate solution, and the precipitate was collected by filtration, and dried under reduced pressure. Phenolic acid A potassium salt 58g, purity 97.50%.
实施例22Example 22
取实施例7制备的丹酚酸A 1260g,以6:4的重量体积比溶解于1030mL水中,加5%氢氧化钠溶液调节pH值至3.5,过滤,收集析出物,减压干燥即得丹酚酸A钠盐812g,纯度99.80%。Take 1260 g of salvianolic acid A prepared in Example 7, dissolved in 1030 mL of water at a weight ratio of 6:4, adjust the pH to 3.5 by adding 5% sodium hydroxide solution, filter, collect the precipitate, and dry it under reduced pressure. The phenolic acid A sodium salt was 812 g, and the purity was 99.80%.
实施例23Example 23
取实施例8制备的丹酚酸A 1600g,以6:4的重量体积比溶解于1310mL水中,加5%氢氧化钠溶液调节pH值至3.5,过滤,收集析出物,减压干燥即得丹酚酸A钠盐948g,纯度99.80%。Take 1600 g of salvianolic acid A prepared in Example 8, dissolved in 1310 mL of water at a weight ratio of 6:4, adjust the pH to 3.5 by adding 5% sodium hydroxide solution, filter, collect the precipitate, and dry it under reduced pressure. Phenolic acid A sodium salt 948g, purity 99.80%.
实施例24Example 24
取实施例9制备的丹酚酸A 1554g,以6:4的重量体积比溶解于1269mL水中,加5%氢氧化钠溶液调节pH值至3.4,过滤,收集析出物,减压干燥即得丹酚酸A钠盐915g,纯度99.80%。1554 g of salvianolic acid A prepared in Example 9 was dissolved in 1269 mL of water at a weight ratio of 6:4, and the pH was adjusted to 3.4 by adding 5% sodium hydroxide solution, and the precipitate was collected by filtration, and dried under reduced pressure. Phenolic acid A sodium salt 915 g, purity 99.80%.
以下为对本发明技术方案的结果分析:The following is an analysis of the results of the technical solution of the present invention:
不同纯度原料在不同pH值下获得丹酚酸A盐纯度,如表1所示。The purity of salvianolic acid A salt was obtained at different pH values for different purity raw materials, as shown in Table 1.
取不同纯度原料丹酚酸A溶解于水中,加碱溶液调节不同pH值,收集析出物干燥即得丹酚酸A盐。The different purity raw materials, salvianolic acid A, are dissolved in water, and an alkali solution is added to adjust different pH values, and the precipitates are collected to obtain salicylic acid A salt.
表1Table 1
Figure PCTCN2018075398-appb-000001
Figure PCTCN2018075398-appb-000001
以不同重量比例溶解得率,如表2所示。The yields were dissolved in different weight ratios as shown in Table 2.
取原料丹酚酸A溶解于不同比例水中,加碱溶液调节pH值3.6,收集析出物干燥即得丹酚酸A盐。The raw material salvianolic acid A is dissolved in different proportions of water, and the pH is adjusted to 3.6 by adding an alkali solution, and the precipitate is dried to obtain salicylic acid A salt.
表2Table 2
Figure PCTCN2018075398-appb-000002
Figure PCTCN2018075398-appb-000002
丹酚酸A成盐前后稳定性比较,如表3所示。The stability of salvianolic acid A before and after salt formation is shown in Table 3.
表3table 3
Figure PCTCN2018075398-appb-000003
Figure PCTCN2018075398-appb-000003
Figure PCTCN2018075398-appb-000004
Figure PCTCN2018075398-appb-000004
结论:由实施例1丹酚酸A制成实施例10丹酚酸A盐、由实施例2丹酚酸A制成实施例11丹酚酸A盐、由实施例3丹酚酸A制成实施例12丹酚酸A盐;从表中数据可知,丹酚酸A放置一年后含量从93%左右降至75%左右,杂质从4%增加至9%,而制成丹酚酸A盐后,放置前后没有变化,所以制成盐后相当稳定。Conclusion: The salicylic acid A salt of Example 10 was prepared from Example 1 and the salicylic acid A salt of Example 11 was prepared from Example 2 salvianolic acid A, and was prepared from Example 3 salvianolic acid A. Example 12 salicylic acid A salt; from the data in the table, the content of salvianolic acid A decreased from about 93% to about 75% after one year of storage, and the impurity increased from 4% to 9%, and the salvianolic acid A was prepared. After the salt, there is no change before and after the placement, so it is quite stable after the salt is formed.
高温、高湿、强光试验High temperature, high humidity, strong light test
表4 高温考察Table 4 High temperature inspection
Figure PCTCN2018075398-appb-000005
Figure PCTCN2018075398-appb-000005
表5 高湿考察Table 5 High humidity inspection
Figure PCTCN2018075398-appb-000006
Figure PCTCN2018075398-appb-000006
表6 光照考察Table 6 Light inspection
Figure PCTCN2018075398-appb-000007
Figure PCTCN2018075398-appb-000007
Figure PCTCN2018075398-appb-000008
Figure PCTCN2018075398-appb-000008
结论:由实施例1丹酚酸A制成实施例10丹酚酸A盐,从高温、高湿、强光实验数据可知,成盐后更加稳定。Conclusion: The salicylic acid A salt of Example 10 was prepared from the salicylic acid A of Example 1. From the experimental data of high temperature, high humidity and strong light, it was found that the salt was more stable after salt formation.
不同纯度丹酚酸A成盐前后溶解度比较,如表7所示。The solubility of salicylate A before and after salt formation was compared as shown in Table 7.
表7Table 7
丹酚酸A实施例Salvianolic acid A example 丹酚酸ASalvianolic acid A 水溶性Water soluble 丹酚酸A盐实施例Salvianolic acid A salt example 丹酚酸A钠盐Salvianolic acid A sodium salt 水溶性Water soluble
66 63%63% 极易溶解Very soluble 1616 92.1%92.1% 略溶Slightly soluble
55 84%84% 极易溶解Very soluble 1717 97.2%97.2% 略溶Slightly soluble
44 91%91% 极易溶解Very soluble 1818 98.6%98.6% 略溶Slightly soluble
图1~4分别为本发明制备的丹酚酸A钠盐的高分辨质谱、 1H NMR谱、 13C NMR谱、HMQC谱。 1 to 4 are respectively high-resolution mass spectrometry, 1 H NMR spectrum, 13 C NMR spectrum, and HMQC spectrum of salvianolic acid A sodium salt prepared by the present invention.
高分辨质谱High resolution mass spectrometry
(1)测试仪器:Qstar Elite(Applietl Biosyhtems/MBS Sclex)(1) Test equipment: Qstar Elite (Applietl Biosyhtems/MBS Sclex)
测定元素:C、H、O、NaDetermination of elements: C, H, O, Na
(2)测定结果如下表8:(2) The measurement results are shown in Table 8 below:
表8 高分辨质谱分析测定结果数据表Table 8 High Resolution Mass Spectrometry Analysis Results Data Sheet
Figure PCTCN2018075398-appb-000009
Figure PCTCN2018075398-appb-000009
高分辨质谱测定数据解析:High resolution mass spectrometry data analysis:
高分辨质谱采用ESI +离子模式,所以高分辨质谱结果得到的分子式比样品分子式多了一个氢。高分辨质谱分析结果显示分子中存在一个钠离子,说明丹酚酸A是以钠盐的形式存在,且本品中丹酚酸A与钠离子是1:1成盐。 High-resolution mass spectrometry uses the ESI + ion mode, so the high-resolution mass spectrometry results in a molecular formula that is one more hydrogen than the sample formula. The results of high-resolution mass spectrometry showed that there was a sodium ion in the molecule, indicating that salvianolic acid A exists in the form of sodium salt, and the salvianolic acid A and sodium ion in this product are 1:1 salt.
1H-NMR核磁共振谱 1 H-NMR nuclear magnetic resonance spectroscopy
(1)仪器:MP-400(1) Instrument: MP-400
溶剂:DMSO-d 6,内标:TMS Solvent: DMSO-d 6 , internal standard: TMS
(2) 1H NMR核磁共振谱,见附图2 (2) 1 H NMR nuclear magnetic resonance spectrum, see Figure 2
Figure PCTCN2018075398-appb-000010
Figure PCTCN2018075398-appb-000010
(3)测定数据见下表9:(3) The measured data is shown in Table 9 below:
表9  1HNMR核磁共振测定数据表 Table 9 1 H NMR nuclear magnetic resonance measurement data sheet
原子序号Atomic number 化学位移chemical shift 峰形Peak shape 质子数Number of protons 相应质子Corresponding proton J(Hz)J (Hz)
A-5A-5 6.806.80 d d 11 Φ-HΦ-H 8.48.4
A-6A-6 7.167.16 d d 11 Φ-HΦ-H 8.48.4
A-7A-7 7.887.88 d d 11 =C-H=C-H 15.615.6
A-8A-8 6.296.29 d d 11 =C-H=C-H 15.615.6
B-2B-2 6.756.75 d d 11 Φ-HΦ-H 8.48.4
B-3B-3 6.476.47 d d 11 Φ-HΦ-H 8.48.4
B-6B-6 6.676.67 s s 11 Φ-HΦ-H
B-7αB-7α 2.812.81 mm 11 -CH 2 -CH 2
B-7βB-7β 3.013.01 dd 11 -CH 2 -CH 2
B-8B-8 4.984.98 ddDd 11 -OCH-OCH
C-2C-2 7.017.01 s s 11 Φ-HΦ-H
C-5C-5 6.606.60 d d 11 Φ-HΦ-H
C-6C-6 6.796.79 d d 11 Φ-HΦ-H
C-7C-7 6.536.53 d d 11 =C-H=C-H 16.816.8
C-8C-8 7.047.04 d d 11 =C-H=C-H 16.216.2
1HNMR核磁共振测定数据解析: 1 H NMR nuclear magnetic resonance data analysis:
(1) 1H-NMR谱出现了δ2.5峰,δ3.2-4.8出现一宽峰,说明分子中存在一个水分子,与样品的TGA数据相吻合。 (1) The 1 H-NMR spectrum showed a peak of δ 2.5, and a broad peak appeared at δ 3.2-4.8, indicating that a water molecule was present in the molecule, which was consistent with the TGA data of the sample.
(2) 1H-NMR谱出现了δ9.03宽峰,约含有6个质子,应为分子中含有的6个酚羟基氢质子。 (2) 1 H-NMR spectrum showed a broad peak of δ 9.03, containing about 6 protons, and should be 6 phenolic hydroxyl hydrogen protons contained in the molecule.
(3)高场区,δ2.81,多重峰,含1个氢质子;δ3.01,双峰,含一个氢质子,分别为亚甲基B7上的2个氢质子,受邻位手性碳的影响,而产生不同的化学位移。δ4.98为与羧基和酯基相连的次甲基碳B8上氢质子信号。(3) High field, δ2.81, multiple peaks, containing one hydrogen proton; δ3.01, doublet, containing one hydrogen proton, respectively two hydrogen protons on methylene B7, subject to ortho chirality The effects of carbon produce different chemical shifts. δ 4.98 is the hydrogen proton signal on the methine carbon B8 attached to the carboxyl group and the ester group.
(4)低场区,δ7.88和δ6.29,各含有1个质子,双峰,偶合常数为15.6,为反式烯氢A7、A8上氢质子,δ7.04和δ6.53,各含有1个质子,双峰,偶合常数约为16.2,为反式烯氢C7、C8上氢质子,说明分子中有2组反式双键氢原子。(4) The low field region, δ7.88 and δ6.29, each containing 1 proton, double peak, coupling constant is 15.6, which is trans-hydrogen A7, hydrogen proton on A8, δ7.04 and δ6.53, each Containing 1 proton, bimodal, coupling constant of about 16.2, is a hydrogen proton on trans-olefinic hydrogen C7, C8, indicating that there are two sets of trans double bond hydrogen atoms in the molecule.
(5)低场区,δ6.2~7.9,共含有12个质子,其中4个为反式烯氢上氢质子,其余8个为芳环氢质子,与分子结构完全一致。(5) The low field region, δ6.2~7.9, contains a total of 12 protons, 4 of which are hydrogen protons on the trans-olefin hydrogen, and the remaining 8 are aromatic ring hydrogen protons, which are completely consistent with the molecular structure.
核磁氢谱数据表明,丹酚酸A钠的核磁氢谱与丹酚酸A的核磁氢谱基本一致,部分氢质子的位移略有偏移。The nuclear magnetic resonance spectrum data showed that the nuclear magnetic resonance spectrum of salvianolic acid A sodium was basically consistent with the nuclear magnetic resonance spectrum of salvianolic acid A, and the displacement of some hydrogen protons was slightly shifted.
13C-NMR核磁共振谱 13 C-NMR nuclear magnetic resonance spectroscopy
(1)仪器:ARX400(1) Instrument: ARX400
溶剂:DMSO-d6,内标:TMSSolvent: DMSO-d6, internal standard: TMS
(2) 13C NMR核磁共振谱,见附图3 (2) 13 C NMR nuclear magnetic resonance spectrum, see Figure 3
C,H相关二维核磁共振(HMQC)谱图见附图4C, H related two-dimensional nuclear magnetic resonance (HMQC) spectrum see Figure 4
(3)测定数据见下表10:(3) The measured data is shown in Table 10 below:
表10  13CNMR核磁共振数据表 Table 10 13 CNMR NMR data sheet
Figure PCTCN2018075398-appb-000011
Figure PCTCN2018075398-appb-000011
13C-NMR核磁共振谱测定数据解析: 13 C-NMR nuclear magnetic resonance spectroscopy data analysis:
(1) 13CNMR谱图共给出25组碳原子信号峰,其中δ119.24含有2个碳质子,说明分子中有26个碳。 (1) 13 CNMR spectra give a total of 25 carbon atom signal peaks, of which δ119.24 contains 2 carbon protons, indicating 26 carbons in the molecule.
(2)高场区,δ36.85为亚甲基碳,在HMQC图中与2个氢相关,为B7位碳;δ74.58为次甲基碳,在HMQC图中与1个氢相关,为B8位碳。与丹酚酸A的碳谱相比较,发现B7位碳的位移略向高场偏移,B8碳的位移则略向低场偏移,这是由于成钠盐的影响。(2) In the high field, δ36.85 is methylene carbon, which is related to two hydrogens in the HMQC diagram, which is B7 carbon; δ74.58 is methine carbon, which is related to one hydrogen in the HMQC diagram. For B8 carbon. Compared with the carbon spectrum of salvianolic acid A, it was found that the displacement of B7 carbon shifted slightly to the high field, and the displacement of B8 carbon shifted slightly to the lower field due to the influence of sodium salt formation.
(3)低场区,δ172.31,为羧酸盐中B9位羰基碳;δ166.43,为酯基中A9位羰基碳。(3) The low field region, δ172.31, is the carbonyl carbon at the B9 position in the carboxylate; δ166.43, which is the carbonyl carbon at the A9 position in the ester group.
(4)化学位移在δ113~148的碳原子为芳环碳原子或烯烃碳原子。其中苯环上未被取代的碳原子的化学位移在δ113~121,化学位移在δ143~147的碳原子为苯环上与羟基相连的碳原子。δ119.24,含有2个碳原子,在HMQC相关图中与2个芳香氢相关。(4) A carbon atom having a chemical shift at δ 113 to 148 is an aromatic ring carbon atom or an olefin carbon atom. The chemical shift of the unsubstituted carbon atom on the benzene ring is δ 113-121, and the carbon atom having a chemical shift of δ 143-147 is a carbon atom connected to the hydroxyl group on the benzene ring. δ 119.24, containing 2 carbon atoms, is associated with 2 aromatic hydrogens in the HMQC correlation diagram.
核磁碳谱数据表明丹酚酸A钠盐的碳谱与丹酚酸A的碳谱相比,羰基碳B9和与之相连的B8碳化学位移略向低场迁移,其他碳原子位移基本一致。The nuclear magnetic carbon spectrum data showed that the carbon spectrum of salvianolic acid A sodium salt compared with the carbon spectrum of salvianolic acid A, the chemical shift of carbonyl carbon B9 and its attached B8 carbon shifted slightly to the low field, and the displacement of other carbon atoms was basically the same.

Claims (9)

  1. 一种丹酚酸A盐的制备方法,其特征在于,所述的制备方法为:A method for preparing salvianolic acid A salt, characterized in that the preparation method is as follows:
    取丹酚酸A溶解于水中,再用碱性物质的水溶液调节pH值为1.2~5.5,收集析出物,即为所述的丹酚酸A盐。The salvianolic acid A is dissolved in water, and the pH is adjusted to 1.2 to 5.5 with an aqueous solution of an alkaline substance, and the precipitate is collected to be the salvianolic acid A salt.
  2. 如权利要求1所述的丹酚酸A盐的制备方法,其特征在于,调节pH值为3.2~4.2。The method for producing salvianolic acid A salt according to claim 1, wherein the pH is adjusted to 3.2 to 4.2.
  3. 如权利要求1所述的丹酚酸A盐的制备方法,其特征在于,所述丹酚酸A与水的料液质量比为1:0.25~4。The method for producing salvianolic acid A salt according to claim 1, wherein the mass ratio of the salvianolic acid A to water is 1:0.25-4.
  4. 如权利要求3所述的丹酚酸A盐的制备方法,其特征在于,所述丹酚酸A与水的料液质量比为1:0.67~1.5。The method for producing a salvianolic acid A salt according to claim 3, wherein a mass ratio of the salvianolic acid A to water is 1:0.67 to 1.5.
  5. 如权利要求1所述的丹酚酸A盐的制备方法,其特征在于,所述碱性物质的水溶液的浓度为1%~15%。The method for producing a salvianolic acid A salt according to claim 1, wherein the aqueous solution of the basic substance has a concentration of from 1% to 15%.
  6. 如权利要求5所述的丹酚酸A盐的制备方法,其特征在于,所述碱性物质的水溶液的浓度为4%~11%。The method for producing a salvianolic acid A salt according to claim 5, wherein the aqueous solution of the basic substance has a concentration of 4% to 11%.
  7. 如权利要求1所述的丹酚酸A盐的制备方法,其特征在于,所述碱性物质的水溶液由如下碱性物质溶于水中配制而成:氢氧化钠、碳酸氢钠、碳酸钠、氢氧化钾、碳酸氢钾、碳酸钾、氢氧化镁、碳酸氢镁、碳酸镁、氢氧化钙、碳酸氢钙、碳酸钙、柠檬酸钠、酒石酸钠、柠檬酸钾、酒石酸钾、柠檬酸镁或酒石酸镁。The method for preparing a salvianolic acid A salt according to claim 1, wherein the aqueous solution of the alkaline substance is prepared by dissolving the following basic substance in water: sodium hydroxide, sodium hydrogencarbonate, sodium carbonate, Potassium hydroxide, potassium hydrogencarbonate, potassium carbonate, magnesium hydroxide, magnesium hydrogencarbonate, magnesium carbonate, calcium hydroxide, calcium hydrogencarbonate, calcium carbonate, sodium citrate, sodium tartrate, potassium citrate, potassium tartrate, magnesium citrate Or magnesium tartrate.
  8. 如权利要求1所述的丹酚酸A盐的制备方法,其特征在于,所述的丹酚酸A由原料丹参经水或乙醇水溶液提取、大孔树脂柱层析分离、聚酰胺层析柱分离制备而得。The method for preparing salvianolic acid A salt according to claim 1, wherein the salvianolic acid A is extracted from the raw material Danshen by water or ethanol aqueous solution, separated by macroporous resin column chromatography, and the polyamide chromatography column is used. Prepared by separation.
  9. 如权利要求8所述的丹酚酸A盐的制备方法,其特征在于,所述的丹酚酸A按如下方法制备得到:The method for preparing salvianolic acid A salt according to claim 8, wherein the salvianolic acid A is prepared as follows:
    (1)将原料丹参按料液质量比1:6~12与水或体积分数10%~90%的乙醇水溶液混合,在70~100℃下提取1~3h,过滤收集滤液,滤渣复提1~3次,合并各次所得滤液,得到丹参提取液;(1) Mixing the raw material Danshen according to the mass ratio of the liquid: 1:6~12 with water or volume fraction of 10%-90% ethanol solution, extracting at 70-100 °C for 1-3 hours, collecting the filtrate by filtration, and extracting the residue. ~3 times, combining the filtrates obtained each time to obtain the extract of Salvia miltiorrhiza;
    (2)取步骤(1)所得丹参提取液,浓缩,调节pH至3.5~6.0,升温至110~130℃加热1~6h,之后冷却至室温,过滤,滤液进行大孔树脂柱层析分离,先用水、体积分数10%~30%乙醇水溶液洗脱除杂,再用体积分数30%~70%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩后继续进行聚酰胺层析柱分离,先用水、体积分数20%~50%乙醇水溶液洗脱除杂,再用体积分数50%~95%乙醇水溶液洗脱,收集含有丹酚酸A的洗脱液,浓缩后调pH值至2~5,经有机溶剂萃取,萃取液经浓缩,干燥,即得所述的丹酚酸A;(2) taking the salvia miltiorrhiza extract obtained in the step (1), concentrating, adjusting the pH to 3.5 to 6.0, heating to 110 to 130 ° C for 1 to 6 hours, then cooling to room temperature, filtering, and separating the filtrate by macroporous resin column chromatography. First elute with water, volume fraction 10% ~ 30% ethanol solution, and then elute with 30% ~ 70% ethanol aqueous solution, collect eluate containing salvianolic acid A, concentrate and continue polyamide chromatography Separation of the column, first elution with water, volume fraction 20% ~ 50% ethanol aqueous solution, and then eluted with 50% ~ 95% ethanol aqueous solution, collect eluate containing salvianolic acid A, concentrate and adjust the pH value To 2 to 5, extracted with an organic solvent, the extract is concentrated and dried to obtain the salvianolic acid A;
    所述的大孔树脂为HPD-100、HPD-100A、HPD-300、HPD-400、HPD-400A、HPD-450、D101、1300-I、1400或AB-8;The macroporous resin is HPD-100, HPD-100A, HPD-300, HPD-400, HPD-400A, HPD-450, D101, 1300-I, 1400 or AB-8;
    所述用于萃取的有机溶剂为乙酸乙酯、乙酸丙酯、乙酸丁酯、正丁醇或异丙醇。The organic solvent used for the extraction is ethyl acetate, propyl acetate, butyl acetate, n-butanol or isopropanol.
PCT/CN2018/075398 2017-02-07 2018-02-06 Method for preparing salvianolic acid a salt WO2018145622A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710067693.X 2017-02-07
CN201710067693.XA CN106748733A (en) 2017-02-07 2017-02-07 A kind of preparation method of salviandic acid A salt

Publications (1)

Publication Number Publication Date
WO2018145622A1 true WO2018145622A1 (en) 2018-08-16

Family

ID=58955277

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/075398 WO2018145622A1 (en) 2017-02-07 2018-02-06 Method for preparing salvianolic acid a salt

Country Status (2)

Country Link
CN (1) CN106748733A (en)
WO (1) WO2018145622A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106748733A (en) * 2017-02-07 2017-05-31 正大青春宝药业有限公司 A kind of preparation method of salviandic acid A salt
CN109748793B (en) * 2018-12-29 2021-07-09 正大青春宝药业有限公司 Method for removing isosalvianolic acid A1 and isosalvianolic acid A2 from sodium salvianolic acid A
CN110403928A (en) * 2019-07-17 2019-11-05 正大青春宝药业有限公司 A kind of salviandic acid A salt composite and its preparation method and application
CN115304486A (en) * 2021-05-06 2022-11-08 台州永健医药科技有限公司 Salvianolic acid A salt hydrate, preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361728A (en) * 2007-08-08 2009-02-11 正大青春宝药业有限公司 Salvianolic acid A injection and preparation method thereof
CN102432467A (en) * 2011-09-30 2012-05-02 吴谢军 Salvianolic acid A magnesium salt, preparation method and use of the salvianolic acid A magnesium salt, and salvianolic acid A magnesium salt-containing freeze-dried powder injection composition
CN105523926A (en) * 2015-12-29 2016-04-27 山东大学 An extracting, separating and purifying method of salvianolic acid A and a preparing method of salvianolic acid salts
CN106748733A (en) * 2017-02-07 2017-05-31 正大青春宝药业有限公司 A kind of preparation method of salviandic acid A salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100999470B (en) * 2006-11-17 2010-12-08 北京本草天源药物研究院 Salvia minium phenolic acid A and process of preparing preparation and use
CN102863338A (en) * 2008-12-30 2013-01-09 北京本草天源药物研究院 Compound and medical use thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361728A (en) * 2007-08-08 2009-02-11 正大青春宝药业有限公司 Salvianolic acid A injection and preparation method thereof
CN102432467A (en) * 2011-09-30 2012-05-02 吴谢军 Salvianolic acid A magnesium salt, preparation method and use of the salvianolic acid A magnesium salt, and salvianolic acid A magnesium salt-containing freeze-dried powder injection composition
CN105523926A (en) * 2015-12-29 2016-04-27 山东大学 An extracting, separating and purifying method of salvianolic acid A and a preparing method of salvianolic acid salts
CN106748733A (en) * 2017-02-07 2017-05-31 正大青春宝药业有限公司 A kind of preparation method of salviandic acid A salt

Also Published As

Publication number Publication date
CN106748733A (en) 2017-05-31

Similar Documents

Publication Publication Date Title
WO2018145622A1 (en) Method for preparing salvianolic acid a salt
RU2529491C2 (en) Salvianolic acid l compound, method of threof preparation and application
JP6976429B2 (en) How to separate 8 ingredients from a Chinese herbal composition
CN101531644B (en) New daphnane diterpene compounds in Daphne genkwa as well as preparation method and application of same
CN104151373B (en) Lignan glycoside compounds and preparation method thereof
WO2017133465A1 (en) Baicalin magnesium, preparation method thereof and application of same
CN113105388B (en) Euphorbia lathyris diterpene alkyl compound and extraction method and application thereof
AU2003242135A1 (en) Preparation Method of Danshentotalphenolic Acid and the Use Thereof
CN106243120B (en) The preparation of Sophora alopecuroide flavones Stilbene class extract and its application in cosmetics
WO2017219510A1 (en) Quinoid chalcone c-glycoside dimer compound having anti-tumor activity and anti-inflammatory activity and method for preparing same
CN101665460A (en) New structural compound neoliensinine and isolation and identification method thereof
CN105461765A (en) Preparation method of amygdalin
CN111018877B (en) Sesquiterpene derivative in elecampane inula root, preparation method and application thereof
CN111560001A (en) Phenolic compound NO84, and preparation method and application thereof
CN105949266A (en) Withana lactide compound, method for extracting same and application of withana lactide compound
CN113278026B (en) Lignin compound with anti-tumor activity and preparation method and application thereof
CN105949272B (en) Wityaphysalin Y and extracting method and purposes
CN103191143A (en) New application of cardiac glycoside compound
CN110204589B (en) Effective component of feather cockscomb seed, extraction method and application thereof in preparing neuroprotective medicament
CN102603833B (en) Extraction and separation process of apigenin-7-O-beta-D-glucopyranside from garden balsam stem
CN115368420B (en) Compound with anti-inflammatory activity and preparation method and application thereof
CN115806491B (en) Terpenoid with nerve cell protection in corn silk and preparation method and application thereof
CN108676054A (en) A kind of triterpene compound and its preparation method and application
CN113024551B (en) Compound extracted and separated from brucea javanica, and preparation method and application thereof
WO2023015548A1 (en) Compound, and preparation method therefor and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18751674

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18751674

Country of ref document: EP

Kind code of ref document: A1